Amrutanjan Health Care Reports Strong Financial Growth Amid Operational Challenges

Amrutanjan Health Care, a small-cap player in the Pharmaceuticals & Biotechnology sector, has recently undergone an evaluation adjustment that reflects notable changes in its financial metrics. The company reported a positive financial performance for the quarter ending June 2025, with significant growth in key indicators. Profit Before Tax (PBT) less Other Income reached Rs 6.86 crore, marking a growth of 261.05%, while Profit After Tax (PAT) stood at Rs 8.31 crore, reflecting a growth of 79.9%. Despite these positive developments, the company faces challenges, particularly with its Debtors Turnover Ratio, which is currently at 8.09 times, indicating potential issues in receivables management. Additionally, Non-Operating Income constitutes 39.24% of PBT, which may raise concerns about the sustainability of earnings. In terms of market performance, Amrutanjan Health Care has shown varied returns compared to the Sensex, with a 1-week return of 8.94% and a 1-year return of -5.22%. The stock is currently trading at Rs 711.35, with a 52-week high of Rs 861.40 and a low of Rs 548.05. Overall, the recent evaluation adjustment highlights the company's strong financial performance amidst certain operational challenges. Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.